annual CFO:
-$134.68M-$42.50M(-46.10%)Summary
- As of today (July 1, 2025), VERA annual cash flow from operations is -$134.68 million, with the most recent change of -$42.50 million (-46.10%) on December 31, 2024.
- During the last 3 years, VERA annual CFO has fallen by -$110.97 million (-468.07%).
- VERA annual CFO is now -1208.96% below its all-time high of -$10.29 million, reached on December 31, 2019.
Performance
VERA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$54.41M-$15.22M(-38.85%)Summary
- As of today (July 1, 2025), VERA quarterly cash flow from operations is -$54.41 million, with the most recent change of -$15.22 million (-38.85%) on March 31, 2025.
- Over the past year, VERA quarterly CFO has dropped by -$20.58 million (-60.82%).
- VERA quarterly CFO is now -2260.35% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
VERA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$155.25M-$20.58M(-15.28%)Summary
- As of today (July 1, 2025), VERA TTM cash flow from operations is -$155.25 million, with the most recent change of -$20.58 million (-15.28%) on March 31, 2025.
- Over the past year, VERA TTM CFO has dropped by -$55.54 million (-55.69%).
- VERA TTM CFO is now -6635.57% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
VERA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VERA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.1% | -60.8% | -55.7% |
| 3 y3 years | -468.1% | -505.8% | -443.5% |
| 5 y5 years | -1209.0% | -2260.3% | -3017.6% |
VERA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -468.1% | at low | -206.1% | at low | -288.8% | at low |
| 5 y | 5-year | -1209.0% | at low | -2123.4% | at low | -3017.6% | at low |
| alltime | all time | -1209.0% | at low | -2260.3% | at low | -6635.6% | at low |
VERA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$54.41M(+38.9%) | -$155.25M(+15.3%) |
| Dec 2024 | -$134.68M(+46.1%) | -$39.18M(+6.2%) | -$134.68M(+11.6%) |
| Sep 2024 | - | -$36.88M(+48.8%) | -$120.64M(+13.0%) |
| Jun 2024 | - | -$24.78M(-26.7%) | -$106.73M(+7.0%) |
| Mar 2024 | - | -$33.83M(+34.5%) | -$99.72M(+8.2%) |
| Dec 2023 | -$92.18M(+36.4%) | -$25.14M(+9.5%) | -$92.18M(+4.5%) |
| Sep 2023 | - | -$22.97M(+29.3%) | -$88.20M(+5.4%) |
| Jun 2023 | - | -$17.77M(-32.4%) | -$83.65M(-1.5%) |
| Mar 2023 | - | -$26.29M(+24.2%) | -$84.91M(+25.6%) |
| Dec 2022 | -$67.60M | -$21.16M(+14.9%) | -$67.60M(+27.8%) |
| Sep 2022 | - | -$18.42M(-3.2%) | -$52.87M(+32.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$19.03M(+111.9%) | -$39.94M(+39.8%) |
| Mar 2022 | - | -$8.98M(+39.5%) | -$28.57M(+20.5%) |
| Dec 2021 | -$23.71M(-31.9%) | -$6.44M(+17.4%) | -$23.71M(-46.9%) |
| Sep 2021 | - | -$5.48M(-28.5%) | -$44.65M(+7.3%) |
| Jun 2021 | - | -$7.67M(+86.0%) | -$41.62M(+13.6%) |
| Mar 2021 | - | -$4.12M(-84.9%) | -$36.63M(+5.2%) |
| Dec 2020 | -$34.81M(+238.3%) | - | - |
| Dec 2020 | - | -$27.38M(+1019.0%) | -$34.81M(+368.7%) |
| Sep 2020 | - | -$2.45M(-8.5%) | -$7.43M(+49.1%) |
| Jun 2020 | - | -$2.67M(+16.1%) | -$4.98M(+116.1%) |
| Mar 2020 | - | -$2.31M | -$2.31M |
| Dec 2019 | -$10.29M | - | - |
FAQ
- What is Vera Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Vera Therapeutics?
- What is Vera Therapeutics annual CFO year-on-year change?
- What is Vera Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vera Therapeutics?
- What is Vera Therapeutics quarterly CFO year-on-year change?
- What is Vera Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Vera Therapeutics?
- What is Vera Therapeutics TTM CFO year-on-year change?
What is Vera Therapeutics annual cash flow from operations?
The current annual CFO of VERA is -$134.68M
What is the all time high annual CFO for Vera Therapeutics?
Vera Therapeutics all-time high annual cash flow from operations is -$10.29M
What is Vera Therapeutics annual CFO year-on-year change?
Over the past year, VERA annual cash flow from operations has changed by -$42.50M (-46.10%)
What is Vera Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VERA is -$54.41M
What is the all time high quarterly CFO for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash flow from operations is -$2.31M
What is Vera Therapeutics quarterly CFO year-on-year change?
Over the past year, VERA quarterly cash flow from operations has changed by -$20.58M (-60.82%)
What is Vera Therapeutics TTM cash flow from operations?
The current TTM CFO of VERA is -$155.25M
What is the all time high TTM CFO for Vera Therapeutics?
Vera Therapeutics all-time high TTM cash flow from operations is -$2.31M
What is Vera Therapeutics TTM CFO year-on-year change?
Over the past year, VERA TTM cash flow from operations has changed by -$55.54M (-55.69%)